Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply

Aliment Pharmacol Ther. 2022 Oct;56(8):1312-1313. doi: 10.1111/apt.17212.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • CD8-Positive T-Lymphocytes
  • Cohort Studies
  • HLA-A2 Antigen*
  • Hepatitis B virus* / genetics
  • Humans
  • Probability

Substances

  • HLA-A2 Antigen